ANDREA RISTAINO: Open Payments
NPI 1578938734 · DELRAY BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,127 in 52 payments from 14 companies in 2025. Trend: 2023 $1,483 · 2024 $767 · 2025 $1,127
Food & beverage: $1,127
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $218 |
| ABBVIE INC. | 10 | $162 |
| Ardelyx, Inc. | 6 | $142 |
| Madrigal Pharmaceuticals | 5 | $123 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $103 |
| Gilead Sciences, Inc. | 4 | $102 |
| Janssen Biotech, Inc. | 4 | $82 |
| Lilly USA, LLC | 3 | $61 |
| Intercept Pharmaceuticals, Inc. | 1 | $25 |
| Aimmune Therapeutics, Inc. | 1 | $25 |
Products named: ENTYVIO, IBSRELA, REZDIFFRA, XIFAXAN, RINVOQ, TREMFYA, OMVOH, EOHILIA.
Industry payments across FL — which companies pay providers there.
